Kimberly Thomas

692 total citations
9 papers, 69 citations indexed

About

Kimberly Thomas is a scholar working on Economics and Econometrics, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Kimberly Thomas has authored 9 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Economics and Econometrics, 2 papers in Infectious Diseases and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Kimberly Thomas's work include Health Systems, Economic Evaluations, Quality of Life (2 papers), Multiple Sclerosis Research Studies (2 papers) and COVID-19 Clinical Research Studies (2 papers). Kimberly Thomas is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (2 papers), Multiple Sclerosis Research Studies (2 papers) and COVID-19 Clinical Research Studies (2 papers). Kimberly Thomas collaborates with scholars based in United States, Switzerland and Canada. Kimberly Thomas's co-authors include Mark W. Johnson, Carlos Zayas, Raymond A. Rubin, Roshan Shrestha, Moogeh Baharnoori, Virender Bhan, Nicholas Adlard, Daniel Grima, François Blanchette and Barkha P. Patel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Liver Transplantation and JONA The Journal of Nursing Administration.

In The Last Decade

Kimberly Thomas

7 papers receiving 66 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kimberly Thomas United States	5	17	16	16	14	13	9	69
Suhua Zhou China	4	20 1.2×	6 0.4×	8 0.5×	12 0.9×	10 0.8×	5	125
Samantha Carmichael Australia	4	18 1.1×	4 0.3×	15 0.9×	21 1.5×	15 1.2×	4	151
J. González-Ramos Spain	6	5 0.3×	36 2.3×	44 2.8×	10 0.7×	8 0.6×	12	170
Charbel Skayem France	7	7 0.4×	6 0.4×	12 0.8×	14 1.0×	5 0.4×	32	104
Л. В. Тарасова Russia	4	7 0.4×	7 0.4×	25 1.6×	16 1.1×	9 0.7×	35	57
Gabriela Kuftinec United States	6	4 0.2×	17 1.1×	73 4.6×	11 0.8×	2 0.2×	14	169
Rebecca Allcock United Kingdom	4	3 0.2×	39 2.4×	17 1.1×	16 1.1×	10 0.8×	9	64
Gabriel Robbins United States	2	4 0.2×	3 0.2×	13 0.8×	40 2.9×	26 2.0×	4	114
K. L. Raikhelson Russia	5	39 2.3×	9 0.6×	36 2.3×	9 0.6×	5 0.4×	19	83
Zhixiong Fang China	9	10 0.6×	10 0.6×	56 3.5×	55 3.9×	13 1.0×	19	176

Countries citing papers authored by Kimberly Thomas

Since Specialization

Citations

This map shows the geographic impact of Kimberly Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Thomas more than expected).

Fields of papers citing papers by Kimberly Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Thomas. The network helps show where Kimberly Thomas may publish in the future.

Co-authorship network of co-authors of Kimberly Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Thomas. A scholar is included among the top collaborators of Kimberly Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Thomas. Kimberly Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Bhan, Virender, Moogeh Baharnoori, Kimberly Thomas, et al.. (2023). Cost–consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada. Journal of Comparative Effectiveness Research. 12(9). e220175–e220175. 4 indexed citations

Kilcoyne, Adrian, et al.. (2022). Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England. SHILAP Revista de lepidopterología. 3 indexed citations

Baharnoori, Moogeh, Virender Bhan, Kimberly Thomas, et al.. (2022). Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada. PharmacoEconomics - Open. 6(6). 859–870. 16 indexed citations

Kilcoyne, Adrian, et al.. (2022). Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective. Journal of Medical Economics. 25(1). 160–171. 5 indexed citations

Thomas, Kimberly, et al.. (2021). Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool. Journal of Community Genetics. 12(1). 129–136. 2 indexed citations

Thomas, Kimberly, et al.. (2021). Reducing Venous Thromboembolism Risk Through a Collaborative Team Approach. Journal of PeriAnesthesia Nursing. 36(5). 452–459.

Farquhar, Marybeth, Ellen T. Kurtzman, & Kimberly Thomas. (2010). What Do Nurses Need to Know About the Quality Enterprise?. The Journal of Continuing Education in Nursing. 41(6). 246–256.

Herrmann, S., et al.. (2009). Hospital Readmission. JONA The Journal of Nursing Administration. 39(11). 462–464. 4 indexed citations

Johnson, Mark W., et al.. (2006). Terbinafine-induced hepatic failure requiring liver transplantation. Liver Transplantation. 13(1). 162–164. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact